104 -5 (79) 2025 - Rizaeva M.J. - CLINICAL CASE OF A PATIENT WIYH ATRIAL FIBRILLATION WITH CORONARY VESSEL ECTASIA

CLINICAL CASE OF A PATIENT WIYH ATRIAL FIBRILLATION WITH CORONARY VESSEL ECTASIA

Rizaeva M.J. - Bukhara State Medical Institute named after Abu Ali ibn Sina, Bukhara branch of the Republican Scientific Center for Emergency Medical Care Uzbekistan

Resume

Atrial fibrillation (AF) is one of the most common versions of supraventricular tachyarrhythmia that a doctor has to deal with in everyday practice. It is believed that fibrillation is an independent risk factor for cardiovascular disease, because cardiac arrhythmia leads to a deterioration in the quality of life of patients, the possibility of thromboembolic complications, leading to sudden cardiac death. In the general population, AF in the adult population is 3%. The prevalence of AF has now doubled compared to previous decades. The prevalence of AF varies with age, gender, and in the presence of structural heart disease

Key words: hemostasis, ischemic heart disease, atrial fibrillation

First page

522

Last page

526

For citation:Rizaeva M.J. - CLINICAL CASE OF A PATIENT WIYH ATRIAL FIBRILLATION WITH CORONARY VESSEL ECTASIA//New Day in Medicine 5(79)2025 522-526 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

  1. Курбанов, Р. Д., Закиров, Н. У., Азизов, Ш. К., & Раубжанов, Х. М. (2012). Возможные предикторы рецидивирования фибрилляции предсердий на фоне длительного профилактического приема пропафенона. Рациональная фармакотерапия в кардиологии, 8 (5), 655-659.
  2. Kirchhof P., Benussi S., Kotecha D. et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016. № 37 (38). Р. 2893-2962 (https://doi.org/10.1093/eurheartj/ehw210)
  3. Kushakovskiy M.S. Atrial fibrillation (causes, mechanisms, clinical forms, treatment, prevention). SPb.: IKF «Foliant»; 1999. Russian (Кушаковский М.С. Фибрилляция предсердий (причины, механизмы клинические формы, лечение, профилактика). СПб.: ИКФ «Фолиант»; 1999).
  4. Kurbanov R.D., Zakirov N.U., Azizov Sh.K. Preventive efficacy of propafenone in patients with recurrent atrial fibrillation. Rossiyskiy kardiologicheskiy zhurnal 2009;6:40-44.
  5. Kannel W.B., Wolf P.A., Benjamin E.J., Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82(8A):2N-9N.
  6. Díaz-Zamudio M, Bacilio-Pérez U, Herrera-Zarza MC, et al. Coronary artery aneurysms and ectasia: role of coronary CT angiography. Radiographics 2009; 29(7): 1939-54.
  7. Kuno T, Numasawa Y Sugiyama K, et al. A rare case of acute myocardial infarction with multivessel coronary artery ectasia successfully treated with percutaneous coronary intervention and systemic thrombolysis. Intern Med. 2015; 54 (9): 1057-62.
  8. Mavrogeni S. Coronary artery ectasia: from diagnosis to treatment. Hellenic J Cardiol. 2010; 51(2):158-63.]. Часто ЭКА приводит к развитию стенокардии. Среди других проявлений: инфаркт миокарда, аритмии, диссекции артерий и внезапная смерть [Díaz-Zamudio M, Bacilio-Pérez U, Herrera-Zarza MC, et al. Coronary artery aneurysms and ectasia: role of coronary CT angiography. Radiographics 2009; 29(7): 1939-54.
  9. M. Zoni-Berisso, F. Lercari, T. Carazza, S. Domeni-cucci. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014; 6: 213-220].
  10. Кужукеев М. Е., Баимбетов А. К., & Абзалиев К. Б. (2017). Фибрилляция предсердий: эпидемиология, этиология, социальная значимость и лечение (обзор литературы). Вестник хирургии Казахстана, (2 (51)), 5-15.

    file

    download